Pasithea Therapeutics (KTTA) Gains from Investment Securities (2021 - 2026)
Pasithea Therapeutics recorded quarterly Gains from Investment Securities of $1.7 million in Q1 2026, up 1014.11% quarter-over-quarter from $151318.0 in Q3 2025, and up 2293.19% year-over-year from $70443.2 in Q1 2025.
Pasithea Therapeutics' Gains from Investment Securities history runs 6 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 2293.19% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 5995.98% YoY), while the FY2025 annual figure was $1.7 million, up 826.11% from the prior year.
- Gains from Investment Securities came in at $1.7 million for Q1 2026 at Pasithea Therapeutics, up from $151318.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.2 million in Q1 2023 to a low of -$980509.0 in Q4 2022.
- A 5-year average of $208881.1 and a median of $3515.0 in 2024 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities plunged 187.72% in 2025 and soared 2293.19% in 2026, its largest moves.
- Pasithea Therapeutics' Gains from Investment Securities stood at -$980509.0 in 2022, then soared by 93.97% to -$59125.0 in 2023, then soared by 97.62% to -$1406.0 in 2024, then jumped by 10862.3% to $151318.0 in 2025, then soared by 1014.11% to $1.7 million in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $1.7 million, $151318.0, and $8436.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Mar 31, 2026 | 1.69 Mn |
| Sep 30, 2025 | 151,318.00 |
| Sep 30, 2025 | 151,318.00 |
| Jun 30, 2025 | 8,436.00 |
| Jun 30, 2025 | 8,436.00 |
| Mar 31, 2025 | -76,867.00 |
| Mar 31, 2025 | -76,867.00 |
| Dec 31, 2024 | -1,406.00 |
| Dec 31, 2024 | -1,406.00 |
| Sep 30, 2024 | 17,649.00 |
| Sep 30, 2024 | 17,649.00 |
| Jun 30, 2024 | 35,622.00 |
| Jun 30, 2024 | 35,622.00 |
| Mar 31, 2024 | 184,643.00 |
| Mar 31, 2024 | 184,643.00 |
| Dec 31, 2023 | -59,125.00 |
| Dec 31, 2023 | -59,125.00 |
| Sep 30, 2023 | -44,996.00 |
| Sep 30, 2023 | -44,996.00 |
| Jun 30, 2023 | -113,426.00 |
| Jun 30, 2023 | -113,426.00 |
| Mar 31, 2023 | 960.00 |
| Mar 31, 2023 | 960.00 |
| Dec 31, 2022 | -2.26 Mn |
| Dec 31, 2022 | -2.26 Mn |
| Sep 30, 2022 | 400,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | -421,700.00 |
| Jun 30, 2022 | -421,700.00 |
| Mar 31, 2022 | 600,000.00 |
| Mar 31, 2022 | 600,000.00 |
| Dec 31, 2021 | -2.59 Mn |
| Dec 31, 2021 | -2.59 Mn |
| Sep 30, 2021 | 252,000.00 |
| Sep 30, 2021 | 252,000.00 |